Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

Etxeberria I, Bolaños E, Quetglas JI, Gros A, Villanueva A, Palomero J, Sánchez-Paulete AR, Piulats JM, Matias-Guiu X, Olivera I, Ochoa MC, Labiano S, Garasa S, Rodriguez I, Vidal A, Mancheño U, Hervás-Stubbs S, Azpilikueta A, Otano I, Aznar MA, Sanmamed MF, Inogés S, Berraondo P, Teijeira Á, Melero I.

Cancer Cell. 2019 Nov 6. pii: S1535-6108(19)30480-5. doi: 10.1016/j.ccell.2019.10.006. [Epub ahead of print]

PMID:
31761658
2.

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Aznar MA, Molina C, Teijeira A, Rodriguez I, Azpilikueta A, Garasa S, Sanchez-Paulete AR, Cordeiro L, Etxeberria I, Alvarez M, Rius-Rocabert S, Nistal-Villan E, Berraondo P, Melero I.

EMBO Mol Med. 2019 Nov 19:e10375. doi: 10.15252/emmm.201910375. [Epub ahead of print]

3.

Metabolic Consequences of T-cell Costimulation in Anticancer Immunity.

Teijeira A, Garasa S, Etxeberria I, Gato-Cañas M, Melero I, Delgoffe GM.

Cancer Immunol Res. 2019 Oct;7(10):1564-1569. doi: 10.1158/2326-6066.CIR-19-0115. Review.

PMID:
31575551
4.

Twists and turns to translating 4-1BB cancer immunotherapy.

Sanmamed MF, Etxeberría I, Otano I, Melero I.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaax4738. doi: 10.1126/scitranslmed.aax4738. Review.

PMID:
31189719
5.

Factors associated with health-related quality of life (HRQoL): differential patterns depending on age.

Etxeberria I, Urdaneta E, Galdona N.

Qual Life Res. 2019 Aug;28(8):2221-2231. doi: 10.1007/s11136-019-02182-0. Epub 2019 May 7.

PMID:
31065936
6.

Immunotherapeutic effects of intratumoral nanoplexed poly I:C.

Aznar MA, Planelles L, Perez-Olivares M, Molina C, Garasa S, Etxeberría I, Perez G, Rodriguez I, Bolaños E, Lopez-Casas P, Rodriguez-Ruiz ME, Perez-Gracia JL, Marquez-Rodas I, Teijeira A, Quintero M, Melero I.

J Immunother Cancer. 2019 May 2;7(1):116. doi: 10.1186/s40425-019-0568-2.

7.

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.

Rodríguez-Ruiz ME, Rodríguez I, Mayorga L, Labiano T, Barbes B, Etxeberria I, Ponz-Sarvise M, Azpilikueta A, Bolaños E, Sanmamed MF, Berraondo P, Calvo FA, Barcelos-Hoff MH, Perez-Gracia JL, Melero I.

Mol Cancer Ther. 2019 Mar;18(3):621-631. doi: 10.1158/1535-7163.MCT-18-0558. Epub 2019 Jan 25.

PMID:
30683810
8.

Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.

Fernández-Eulate G, Alberro A, Muñoz-Culla M, Zulaica M, Zufiría M, Barandiarán M, Etxeberria I, Yanguas JJ, Gallardo MM, Soberón N, Lacosta AM, Pérez-Grijalba V, Canudas J, Fandos N, Pesini P, Sarasa M, Indakoetxea B, Moreno F, Vergara I, Otaegui D, Blasco M, López de Munain A.

Front Aging Neurosci. 2018 Nov 28;10:380. doi: 10.3389/fnagi.2018.00380. eCollection 2018.

9.

Cytokines in clinical cancer immunotherapy.

Berraondo P, Sanmamed MF, Ochoa MC, Etxeberria I, Aznar MA, Pérez-Gracia JL, Rodríguez-Ruiz ME, Ponz-Sarvise M, Castañón E, Melero I.

Br J Cancer. 2019 Jan;120(1):6-15. doi: 10.1038/s41416-018-0328-y. Epub 2018 Nov 9. Review.

10.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

Sánchez-Paulete AR, Teijeira Á, Quetglas JI, Rodríguez-Ruiz ME, Sánchez-Arráez Á, Labiano S, Etxeberria I, Azpilikueta A, Bolaños E, Ballesteros-Briones MC, Casares N, Quezada SA, Berraondo P, Sancho D, Smerdou C, Melero I.

Cancer Res. 2018 Dec 1;78(23):6643-6654. doi: 10.1158/0008-5472.CAN-18-0933. Epub 2018 Oct 8.

11.

An RNA toolbox for cancer immunotherapy.

Pastor F, Berraondo P, Etxeberria I, Frederick J, Sahin U, Gilboa E, Melero I.

Nat Rev Drug Discov. 2018 Oct;17(10):751-767. doi: 10.1038/nrd.2018.132. Epub 2018 Sep 7. Review.

PMID:
30190565
12.

Epistatic Oncogenic Interactions Determine Cancer Susceptibility to Immunotherapy.

Etxeberria I, Teijeira A, Montuenga LM, Berraondo P, Melero I.

Cancer Discov. 2018 Jul;8(7):794-796. doi: 10.1158/2159-8290.CD-18-0573.

13.

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.

Teijeira A, Labiano S, Garasa S, Etxeberria I, Santamaría E, Rouzaut A, Enamorado M, Azpilikueta A, Inoges S, Bolaños E, Aznar MA, Sánchez-Paulete AR, Sancho D, Melero I.

Cancer Immunol Res. 2018 Jul;6(7):798-811. doi: 10.1158/2326-6066.CIR-17-0767. Epub 2018 Apr 20.

14.

Revisiting Interleukin-12 as a Cancer Immunotherapy Agent.

Berraondo P, Etxeberria I, Ponz-Sarvise M, Melero I.

Clin Cancer Res. 2018 Jun 15;24(12):2716-2718. doi: 10.1158/1078-0432.CCR-18-0381. Epub 2018 Mar 16.

15.

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.

Ochoa MC, Minute L, López A, Pérez-Ruiz E, Gomar C, Vasquez M, Inoges S, Etxeberria I, Rodriguez I, Garasa S, Mayer JA, Wirtz P, Melero I, Berraondo P.

Oncoimmunology. 2017 Nov 13;7(2):e1393597. doi: 10.1080/2162402X.2017.1393597. eCollection 2018.

16.

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Azpilikueta A, Bolaños E, Lang V, Labiano S, Aznar MA, Etxeberria I, Teijeira A, Rodriguez-Ruiz ME, Perez-Gracia JL, Jure-Kunkel M, Zapata JM, Rodriguez MS, Melero I.

Oncoimmunology. 2017 Sep 21;7(1):e1368605. doi: 10.1080/2162402X.2017.1368605. eCollection 2017.

17.

CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes.

Aznar MA, Labiano S, Diaz-Lagares A, Molina C, Garasa S, Azpilikueta A, Etxeberria I, Sanchez-Paulete AR, Korman AJ, Esteller M, Sandoval J, Melero I.

Cancer Immunol Res. 2018 Jan;6(1):69-78. doi: 10.1158/2326-6066.CIR-17-0159. Epub 2017 Nov 13.

18.

Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy.

Pérez-Ruiz E, Etxeberria I, Rodriguez-Ruiz ME, Melero I.

Clin Cancer Res. 2017 Sep 15;23(18):5326-5328. doi: 10.1158/1078-0432.CCR-17-1799. Epub 2017 Aug 8.

19.

Cellular immunotherapies for cancer.

Berraondo P, Labiano S, Minute L, Etxeberria I, Vasquez M, Sanchez-Arraez A, Teijeira A, Melero I.

Oncoimmunology. 2017 May 2;6(5):e1306619. doi: 10.1080/2162402X.2017.1306619. eCollection 2017. Review.

20.

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

Labiano S, Meléndez-Rodríguez F, Palazón A, Teijeira Á, Garasa S, Etxeberria I, Aznar MÁ, Sánchez-Paulete AR, Azpilikueta A, Bolaños E, Molina C, de la Fuente H, Maiso P, Sánchez-Madrid F, de Landázuri MO, Aragonés J, Melero I.

Oncoimmunology. 2017 Jan 19;6(4):e1283468. doi: 10.1080/2162402X.2017.1283468. eCollection 2017.

21.

Profiles in emotional aging: does age matter?

Etxeberria I, Etxebarria I, Urdaneta E.

Aging Ment Health. 2018 Oct;22(10):1304-1312. doi: 10.1080/13607863.2017.1286450. Epub 2017 Feb 17.

PMID:
28282728
22.

Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium.

Rodriguez-Ruiz ME, Garasa S, Rodriguez I, Solorzano JL, Barbes B, Yanguas A, Teijeira A, Etxeberria I, Aristu JJ, Halin C, Melero I, Rouzaut A.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):389-400. doi: 10.1016/j.ijrobp.2016.10.043. Epub 2016 Nov 7.

PMID:
28068246
23.

Immunotherapy of Cancer Visualized by Live Microscopy: Seeing Is Believing.

Teijeira A, Etxeberria I, Ponz-Sarvise M, Melero I.

Clin Cancer Res. 2016 Sep 1;22(17):4277-9. doi: 10.1158/1078-0432.CCR-16-1072. Epub 2016 Jun 21.

24.

Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.

Sanchez-Paulete AR, Labiano S, Rodriguez-Ruiz ME, Azpilikueta A, Etxeberria I, Bolaños E, Lang V, Rodriguez M, Aznar MA, Jure-Kunkel M, Melero I.

Eur J Immunol. 2016 Mar;46(3):513-22. doi: 10.1002/eji.201445388. Epub 2016 Feb 9. Review.

25.

Age differences among older adults in the use of emotion regulation strategies. What happens among over 85s and centenarians?

Etxeberria I, Etxebarria I, Urdaneta E, Yanguas JJ.

Aging Ment Health. 2016 Sep;20(9):974-80. doi: 10.1080/13607863.2015.1050995. Epub 2015 Jun 8.

PMID:
26054254
26.

Confirmatory factor analysis of the familism scale in a sample of dementia caregivers.

Losada A, Knight BG, Márquez-González M, Montorio I, Etxeberría I, Peñacoba C.

Aging Ment Health. 2008 Jul;12(4):504-8. doi: 10.1080/13607860802224227.

PMID:
18791899
27.

A randomized, two-year study of the efficacy of cognitive intervention on elderly people: the Donostia Longitudinal Study.

Buiza C, Etxeberria I, Galdona N, González MF, Arriola E, López de Munain A, Urdaneta E, Yanguas JJ.

Int J Geriatr Psychiatry. 2008 Jan;23(1):85-94.

PMID:
17530622
28.

Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population.

Blázquez L, De Juan D, Ruiz-Martínez J, Emparanza JI, Sáenz A, Otaegui D, Sistiaga A, Martínez-Lage P, Lamet I, Samaranch L, Buiza C, Etxeberria I, Arriola E, Cuadrado E, Urdaneta E, Yanguas J, López de Munain A.

Neurobiol Aging. 2007 Dec;28(12):1941-3. Epub 2006 Oct 2.

PMID:
17011669
29.

GMR effect in CuCo annealed melt-spun ribbons.

Murillo N, Grande H, Etxeberria I, Del Val JJ, González J, Arana S, Gracia FJ.

J Nanosci Nanotechnol. 2004 Nov;4(8):1056-61.

PMID:
15656202

Supplemental Content

Loading ...
Support Center